The global immunoprecipitation market is predicted to evolve at a CAGR of 6% and reach a size of US$ 830 million by the end of 2027, as per data released by Fact.MR, a market research and competitive intelligence provider.
The immunoprecipitation (IP) technique is widely used to separate a specific protein antigen from a sample that contains a variety of proteins. The antibody needs to be coupled with a solid substrate for this process. The procedure of immunoprecipitation is used to remove protein from biological materials. This solution is used in several different ways to study the interactions of the main antigen protein with other proteins and nucleic acids.
For In-depth Analysis & Business Strategy, Buy a Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=7779
A common objective is to thoroughly examine the cellular elements or interactors connected to the main antigen. Proteins and several other biomolecules can be separated from tissue or cell lysates using the commonly used process of immunoprecipitation. These biomolecules are then analyzed using assay methods such as western blotting.
Rising efforts by governments and businesses in biotechnology research & development and growing awareness of personalized treatments are the elements boosting market value. The global immunoprecipitation market is anticipated to increase as a result of the rising trend of clinical research. The frequency of autoimmune illnesses, which necessitate testing for antibody-antigen interactions, is driving market expansion.
Growth of research programs and initiatives in the life sciences sector, expansion of R&D partnerships between academic institutions and top pharmaceutical companies, development of immunoprecipitation techniques, and high demand for drugs that target the identification of autoimmune disease-related antigens are also driving market revenue growth.
Key Takeaways from Market Study
- The global immunoprecipitation market is currently valued at US$ 620 million.
- Market in Canada is anticipated to progress at a CAGR of 5% over the forecast period (2022-2027).
- Market in Germany is predicted to rise at a CAGR of 4.5% through 2027.
- Demand for accessories is expected to accelerate at a CAGR of 5.1% from 2022 to 2027.
“Market value is being significantly fueled by recent advancements in the application of immunoprecipitation in genomic studies, increasing number of academic & research institutions, growing research activities in life sciences, rapid innovations in chromatin immunoprecipitation techniques, and expanding biotechnology research,” says a Fact.MR analyst
For critical insights on this market, request for More Info – https://www.factmr.com/connectus/sample?flag=AE&rep_id=7779
Winning Strategy
Top market players are outsourcing drug development efforts to contract research organizations to grow their profit margins. Key companies are developing novel techniques to boost their market share globally.
For instance,
- Merck revealed its ambitions to create a new life science center that will concentrate on immunology, cancer, and immuno-oncology.
- In 2022, through its Sigma-Aldrich division MilliporeSigma, granted a license for the use of its catalogue of CRISPR-related intellectual property to Israeli agbio company BetterSeeds.
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global immunoprecipitation market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2027.
The study divulges essential insights on the market on the basis of type (individual protein immunoprecipitation, chromatin immunoprecipitation, co-immunoprecipitation, RNA immunoprecipitation), component (reagents, kits, accessories), and end user (academic & research institutes, pharma & biopharma companies, contract research organizations), across five major regions (North America, Europe, Asia Pacific, Latin America, and MEA).
Segments of Immunoprecipitation Industry Research
-
By Type :
- Individual Protein Immunoprecipitation
- Chromatin Immunoprecipitation
- Co-immunoprecipitation
- RNA Immunoprecipitation
-
By Component :
- Reagents
- Kits
- Accessories
-
By End User :
- Academic & Research Institutes
- Pharma & Biopharma Companies
- Contract Research Organizations
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Choose Quick and Secure PayPal Payment Mode to Get Full Access of This Report – https://www.factmr.com/checkout/7779
Contact:
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232 (D)
Tel: +353-1-6111-593 (Dublin 2)
E-Mail: sales@factmr.com